Chemical formula: C₂₂H₂₇NO₂ Molecular mass: 337.455 g/mol PubChem compound: 28417
Danazol is indicated for:
Population group: women, only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Danazol is recommended for the treatment of endometriosis-associated symptoms or/and to reduce the extent of endometriosis foci. Danazol may be used either in conjunction with surgery or, as sole hormonal therapy, in patients not responding to other treatments.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: women, only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Danazol is recommended for the treatment of benign fibrocystic breast disease. Symptomatic relief of severe pain and tenderness. Danazol should be used only in patients not responsive to other therapeutic measures or for whom such measures are inadvisable.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 - 65 years old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Danazol is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.